Methazolamide
Overview
Methazolamide is an inhibitor of carbonic anhydrase.It is a sulfonamide derivative;however it does not have any clinically significant antimicrobial properties.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Methazolamide's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 50 to 100 mg | 75 (75) | 12 hourly | oral | 2 or 3 times daily by mouth. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Methazolamide is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Methazolamide is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Methazolamide
Back to top
Previous Drug Generic - Next Drug Generic